Holds a Bachelor's degree in Biomedical Science from the State University of Minas Gerais, Passos campus (UEMG-Passos) (2015), a Masters (2017) and Ph.D. (2023) in Sciences from the Faculty of Medicine at the University of São Paulo, with a focus on molecular biology and genetics, investigating molecular markers and microRNAs in urological diseases. Currently, a Postdoctoral Fellow in the Department of Immunology and Immunotherapy at the Icahn School of Medicine at Mount Sinai, New York, conducting research on the expression of tumor markers, such as MICA/B, in acute myeloid leukemia (AML). His studies also explore the interaction between Natural Killer (NK) cells and leukemic cells, aiming to develop new antitumor immunotherapy strategies. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Prostate Cancer (PCa) is characterized by slow growth and represents a type of androgen dependent neoplasia. The Androgen Receptor (AR) plays a key ro le in prostate carcinogenesis and metastasis. Thus, Androgen Deprivation Therapies (ADT) are often used to treat PCa. However, at the time when PCa acquired castration-resistant phenotype (CPRC), ADT is no longer effective. In fact, it is n…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID